The intestinal component of a graft-versus-host reaction (GvHR) provides a useful experimental model to elucidate the pathogenesis of clinical enteropathies which cause villus atrophy and crypt hyperplasia and which are associated with a local immune response. One to three days after induction of GvHR in heavily irradiated (CBAxBALB/c)F, mice, a proliferative form of enteropathy developed. Compared with controls, these mice had increased counts of jejunal intraepithelial lymphocytes and had a four-fold increase in crypt cell production rate as well as an increase in crypt length. These changes were accompanied by a marked enhancement of splenic natural killer cell activity. After day three, the crypt cell production rate fell to zero and cytotoxic T lymphocytes (CTL) which could lyse targets of host origin appeared. In parallel, mice with GvHR developed significant villus shortening and their clinical condition deteriorated. Further experiments showed that increased counts of intraepithelial lymphocytes, villus atrophy and crypt hyperplasia also occurred in grafts of fetal CBA intestine implanted under the kidney capsule of (CBAxBALB/c)Fl mice with GvHR. As these grafts are syngeneic to the injected CBA spleen cells, they should not be attacked by anti-host cytotoxic T lymphocytes. We suggest that the proliferative and destructive components of enteropathy in GvHR are caused by lymphokines released by an antihost delayed type hypersensitivity reaction.
damage is the result of recognition of Class II major histocompatibility complex (MHC) alloantigens on bone marrow-derived cells by T cells with the helper/ inducer phenotype.; 8 Together, these features suggest that intestinal damage in this model of GvHR is because of a local delayed type hypersensitivity response, rather than a direct cytotoxic attack on host epithelial cells.
Thus, we have proposed that a similar delayed type hypersensitivity reaction underlies the crypt hyperplasia and increased density of intraepithelial lymphocytes found in naturally occurring enteropathies associated with local cell mediated immunity. Nevertheless, the most characteristic finding in these clinical enteropathies is villus atrophy and we have been unable so far to reproduce this feature using a GvHR in mature, unirradiated mice. 5"' Therefore, it remains possible that villus atrophy is caused by a different mechanism from that which causes crypt hyperplasia. Earlier studies did indicate that small intestinal villus atrophy occurred during a lethal GvHR in irradiated hosts,'"-'2 but the pathogenesis of intestinal damage in this model was not investigated in detail. The present studies were designed firstly to examine whether the intestinal component of GvHR in irradiated mice would reproduce the more severe features of clinical enteropathies and, secondly, to study the immunological basis of this form of GvHR. We have therefore assessed in parallel the evolution of intestinal damage and development of specific and non-specific cytotoxicity in irradiated (CBAxBALB/c)Fl mice with GvHR.
Methods

MICE
CBA(H-2k), and (CBAx BALB/c)Fl (H-2kx,') mice of both sexes were obtained from departmental stocks. All mice were first used at 12-16 weeks of age.
PREPARATION OF LYMPHOCYTES
Spleens and thymuses were removed immediately after donor mice had been killed and single cell suspensions prepared by mincing tissues through a fine wire mesh filter into RPMI 1640 (Gibco Biocult) supplemented with 5% newborn calf serum (Gibco Biocult). After washing three times in medium, cells were counted and viability assessed by phase contrast microscopy.
INDUCTION OF GVHR
Host mice received 950 rads irradiation from a 300KeV x-ray source (Dynaray) at a distance of 100 cm and a dose rate of 250 rad/min. Twenty four hours later, mice were reconstituted with 4x 1(-viable spleen cells iv and were then maintained on drinking water containing 100 mg/l neomycin sulphate (Sigma) . As controls for the radiosensitivity and regeneration of host type natural killer cells, host mice were left unreconstituted after irradiation, while irradiated mice of donor origin were reconstituted with syngeneic spleen cells to assess the regeneration of donor natural killer cells in a syngeneic environment. Control mice in studies of intestinal GvHR were F, mice reconstituted with syngeneic cells, to assess mucosal regeneration under normal conditions.
IMPILANTATION OF ANTIGEN FREER GRAI-TS OF INTESTINE
Pieces of foetal small intestine were implanted under the kidney capsule of adult (CBAxBALB/c)Fl mice as described previously.' ' Briefly, animals were anaesthetised with Sagatal (M & B Ltd) and a 1-2 mm piece of small intestine from 18-19 day old fetuses of either CBA or (CBAxBALB/c)F1 origin was placed under the capsule of each kidney, using a 21G plastic cannula (Argyle Medicut). The grafts were allowed to vascularise for five to six weeks before host animals were irradiated and a GvIIR induced as described above.
MEASUREMENT OF SPECIFIC AND NON-SPECIFIC CYTOTOXICITY Natural killer activity was assayed using YAC-1 target cells, while P815 mastocytoma cells were used to measure H-2'-specific cytotoxic T lymphocyte activity, using a standard microcytotoxicity assay described in detail elsewhere. (2)). Thereafter, the CCPR recovered rapidly and this was paralleled by a progressive increase in crypt length (Fig. 3a) . Similar results were found on examination of the intestine of irradiated F1 mice not reconstituted with spleen cells (data not shown).
Mice with GvHR had a significantly increased CCPR on day one ( 
colchicine. This feature could also be observed using conventional histology. The GvHR specimens suitable for analysis on day five also showed a very low CCPR which was significantly less than in control mice. In parallel with these changes in CCPR, mice with GvHR had significant crypt lengthening on days one and two, reaching a maximum of 207 8 (16(0) [tmondaythree (Fig. 3av 188-3(11-5) (CBAXBALB/C) Fl MICE WITH GVHR The evolution of the antihost immune response in GvHR was followed by assessing specific antihost cytotoxic T lymphocyte activity and by measuring the level of splenic natural killer cell activity, which we have shown previously to reflect the non-specific effects of antihost delayed type hypersensitivity.7 15 The splenic natural killer activity of F1 mice was virtually eliminated by the dose of irradiation used and remained very low throughout the seven days of study (Fig. 4b ). Spleen natural killer activity was also absent in CBA hosts reconstituted with syngeneic CBA spleen cells until two to three days after cell transfer, when a progressive recovery began. In contrast, in GvHR mice, significant natural killer levels were already apparent on day one and rose to a peak on days two to three, when syngeneically reconstituted mice still had little or no natural killer activity. Thereafter, natural killer activity in GvHR Days after induction of GvHR mice fell rapidly to zero after day four. The lysis of YAC-1 (H-2k d) cells did not merely reflect specific recognition of host-type H-2d alloantigens as there was clearly a reciprocal relationship between the ability of GvHR cells to lyse YAC-1 and specific H-2d+ P815 targets (see below). Specific cytotoxic T lymphocyte activity did not appear in mice with GvHR until day three and peaked on day four, when natural killer activity was already markedly depressed (Fig. 4a ). Cytotoxic T lymphocyte activity then declined as the clinical condition of the mice deteriorated.
Thus, enhanced natural killer activity occurs very soon after inducing a GvHR in irradiated mice and a marked decrease in natural killer levels coincides with the parallel development of specific cytotoxic T lymphocyte activity and the onset of overt disease.
INTESTINAL PATHOLOGY OCCURS AS A BYSTANDER PHENOMENON OF GVHR
The close association between the appearance of cytotoxic T lymphocytes and villus atrophy suggested that the mucosal destruction was due to a cytotoxic attack on (Fig. 5a ). On day five of the GvHR, grafts of F1 intestine had significant villus atrophy compared with control grafts implanted in syngeneically reconstituted hosts (258 (25.4) Fxm v 468-2 (35.8) im p<0 001). At this time, the grafts in GvHR mice also still had significant crypt lengthening and a marked increase in CCPR compared with control grafts. The important finding from this experiment was that grafts of CBA gut developed identical intestinal changes when implanted in F1 mice with GvHR, with significant villus atrophy (293. 4 (40.9) [im p<0001), crypt lengthening (188-5 (31.7) Atm v 130 5 [im p<0-001) and increased CCPR compared with control grafts. Furthermore, both F1 and CBA grafts in mice with GvHR showed significant increases in intraepithelial lymphocyte counts compared with controls ( Fig. 5b 5-4 (0.5) and 5 7 (2.2) respectively v 1-1 (1-1) ). Thus, the intestinal pathology occurs even when the gut itself is syngeneic to the donor cells used to induce the GvHR and should not be due to direct attack by specific cytotoxic T lymphocytes.
Discussion
The results presented here show that a GvHR in irradiated mice produces a biphasic enteropathy, each stage of which is accompanied by distinct forms of antihost cell mediated immunity. An initial proliferative stage of intestinal GvHR is associated with a marked enhancement of non-specific cytotoxicity, while the onset of the destructive phase is accompanied by the appearance of specific antihost cytotoxic T lymphocyte activity. Nevertheless, all the intestinal features occur in tissue which is syngeneic to the donor cells used to induce the GvHR, indicating that specific cytotoxic T lymphocytes are not essential for the development of either crypt hyperplasia or villus atrophy.
The mucosal alterations found in the first two to three days of GvHR in irradiated mice were characterised by early increases in CCPR and in intraepithelial lymphocyte count and thus are identical to those found throughout the entirely proliferative GvHR in unirradiated mice.5 h It should be noted that as the crypt hyperplasia preceded the development of villus atrophy in the present study and occurs when villus atrophy is absent in unirradiated hosts, it must be a primary consequence of the GvHR. In both instances, the crypt hyperplasia is paralleled by enhanced natural killer cell activity and occurs in the absence of significant specific cytotoxic T lymphocyte activity. The principal focus of the current investigation was to study the pathogenesis of a destructive enteropathy which included villus atrophy. Our results showed that villus atrophy was a feature of established GvHR which paralleled the clinical deterioration of the mice and which was associated with the appearance of specific antihost cytotoxic T lymphocytes. Although the simplest explanation for the development of villus atrophy would be that antihost cytotoxic T lymphocytes exert a direct cytotoxic effect against host enterocytes, this explanation is not compatible with our finding that an identical pattern of mucosal pathology occurred in grafts of fetal CBA intestine which were syngeneic to the donor cells used to induce the GvHR. As the epithelium of these grafts does not present an allogeneic target to specific effector cells, antihost cytotoxic T lymphocytes cannot cause the destructive enteropathy found in this experiment. A 'bystander phenomenon' has been described previously in intestinal grafts during a proliferative GvHR in unirradiated mice and is normally ascribed to the action of lymphocytederived soluble mediators.5 '" Although necrotic and proliferative changes have been noted in syngeneic gut grafts implanted in irradiated mice with GvHR, these alterations have not been quantified previously"7 and our study is the first to detail the development of villus atrophy as a bystander phenomenon in GvHR. Thus, soluble mediators may not only be responsible for the crypt hyperplasia and recruitment of lymphocytes, found during a proliferative enteropathy, but may also cause the more severe form of enteropathy characterised by villus atrophy. We suggest that the transition from mucosal proliferation to destruction may reflect continued or Mowat, Felstein, Borland, and Parrott unusually high production of lymphokines released by the rapidly progressive antihost immune response which occurs in irradiated hosts. In addition, we consider the cytotoxic T lymphocytes appear as an epiphenomenon of this sustained antihost immune response, because of high levels of mediators such as interleukin 2 or y-interferon (IFN).
One additional feature of the transition from a proliferative to a destructive enteropathy was that the appearance of villus atrophy was preceded by the sudden cessation of crypt cell mitotic activity. This phenomenon has been found in subsequent experiments on this model of GvHR and is cl'=arly an important component of intestinal GvHR in irradiated hosts. As lymphokines such as IFN or lymphotoxin, are cytostatic to a wide range of tissue cells'9" inhibition of epithelial cell turnover may be the lymphokine mediated event which contributes to mucosal destruction. We are currently studying this possibility in more detail and it would also be of interest to examine whether a similar inhibition of cell proliferation occurs in other tissues of irradiated mice at the same stage of a GvHR.
In conclusion, our results indicate that the destructive intestinal pathology caused by a GvHR in irradiated mice reflects the extreme consequences of the same mucosal cell mediated immune response which causes a proliferative enteropathy in unirradiated mice with GvHR. Together with previous work, our study suggests that this intestinal cell mediated immune response has many features of a local delayed type hypersensitivity reaction and that lymphokines play the major pathogenic role. The pattern of mucosal pathology in GvHR is similar to that found in clinical enteropathies, including coeliac disease and CMPI, supporting the hypothesis that these disorders reflect a biphasic response of the mucosa to lymphokines released during a delayed type hypersensitivity response to local antigen. 
